Neulussheim, Germany

Jürgen Mistele

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jürgen Mistele: Innovator in Glycated Protein Stabilization

Introduction

Jürgen Mistele is a notable inventor based in Neulussheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the stabilization of glycated proteins. His innovative approach has implications for various applications in diagnostics and research.

Latest Patents

Mistele holds a patent for a process aimed at stabilizing the content of glycated protein in a sample on a matrix material. The patent describes a method characterized by the impregnation of the matrix material with a boric acid buffer with a pH of 10.5 or higher, or a transition metal salt. This invention enhances the reliability of sample analysis, which is crucial in medical diagnostics.

Career Highlights

Jürgen Mistele is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to focus on innovative solutions that improve the accuracy and efficiency of diagnostic processes. Mistele's expertise in glycated proteins has positioned him as a valuable asset in the research and development sector.

Collaborations

Mistele has collaborated with Rolf Nagel, contributing to advancements in their shared field of expertise. Their partnership has fostered innovation and has led to the development of effective methodologies in protein stabilization.

Conclusion

Jürgen Mistele's contributions to the field of glycated protein stabilization exemplify the impact of innovative thinking in medical diagnostics. His patent and work at Roche Diagnostics GmbH highlight the importance of research and collaboration in advancing healthcare technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…